Pharming Group N.V. ADS, each representing 10 ordinary shares PHAR
$11.81
-4.37%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 6-K | 6-K | 2026-08-13 | View → |
| 6-K | 6-K | 2026-07-30 | View → |
| 6-K | 6-K | 2026-06-04 | View → |
| 6-K | 6-K | 2026-05-28 | View → |
| 6-K | 6-K | 2026-05-22 | View → |
| 6-K | 6-K | 2026-05-07 | View → |
| 6-K | 6-K | 2026-05-07 | View → |
| 6-K | 6-K | 2026-04-16 | View → |
| 6-K | 6-K | 2026-04-02 | View → |
| 20-F | 20-F | 2026-04-02 | View → |
| 6-K | 6-K | 2026-03-27 | View → |
| 6-K | 6-K | 2026-03-24 | View → |
| 6-K | 6-K | 2026-03-12 | View → |
| 6-K | 6-K | 2026-02-03 | View → |
| 6-K | 6-K | 2026-02-02 | View → |
| 6-K | 6-K | 2026-01-08 | View → |
| 6-K | 6-K | 2025-11-06 | View → |
| 6-K | 6-K | 2025-10-22 | View → |
| 6-K | 6-K | 2025-10-06 | View → |
| 6-K | 6-K | 2025-10-01 | View → |
| 6-K | 6-K | 2025-09-10 | View → |
| 6-K | 6-K | 2025-09-02 | View → |
| 6-K | 6-K | 2025-07-31 | View → |
| 6-K | 6-K | 2025-06-24 | View → |
| 6-K | 6-K | 2025-06-11 | View → |
| 6-K | 6-K | 2025-05-08 | View → |
| 6-K | 6-K | 2025-04-30 | View → |
| 6-K | 6-K | 2025-04-25 | View → |
| 6-K | 6-K | 2025-04-23 | View → |
| 6-K | 6-K | 2025-04-03 | View → |
| 20-F | 20-F | 2025-04-03 | View → |
| 6-K | 6-K | 2025-03-20 | View → |
| 6-K | 6-K | 2025-03-13 | View → |
| 6-K | 6-K | 2025-03-04 | View → |
| 6-K | 6-K | 2025-02-20 | View → |
| 6-K | 6-K | 2025-02-07 | View → |
| 6-K | 6-K | 2025-01-21 | View → |
| 6-K | 6-K | 2025-01-21 | View → |
| 6-K | 6-K | 2024-12-16 | View → |
| 6-K | 6-K | 2024-12-11 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $11.81
- Market Cap
- $837.31 million
- 52-Week Range
- $9.54 – $21.34
- Average Volume
- 16K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.
